Tularemia
On this page:
- FAQs & Fact Sheets
- Diagnosis/Evaluation
- Treatment/PEP
- Lab Testing
- Surveillance & Investigation
- Infection Control
- Other Resources
FAQs & Fact Sheets
Diagnosis & Evaluation
Treatment/Postexposure Prophylaxis
Lab Testing
- Basic Protocols for Level A Laboratories for the Presumptive Identification of Francisella tularensis
(203 KB/7 pages)
NOTE: Protocols for sentinel laboratories are no longer posted on the CDC website. The American Society for Microbiology has agreed to take the lead in the development & dissemination of sentinel laboratory information. Information for reference laboratories will continue to be available on the Laboratory Response Network secure website (for questions, e-mail lrn@cdc.gov; tollfree HelpDesk 1-866-LRN-LABS [1-866-576-5227]). The CDC subject matter experts on individual organisms remain available for discussion as always. -
MMWR: Recognition
of Illness Associated with the Intentional Release of a
Biologic Agent
MMWR 2001 Oct 19;50(41):893-897.
(168 KB/20 pages)
Surveillance & Investigation
- Epidemiology
(from "Consensus Statement: Tularemia as a Biological
Weapon: Medical and Public Health Management")
JAMA 1999;281(18):1735-1745. See also thefull version of the "Epidemiology" section of the "Consensus Statement" (JAMA 2001; 285(21):2763-73). - Tularemia Surveillance Case Definitions
- EID Journal: Francisella tularensis in the United States
Emerging Infectious Diseases 2005 Dec;11(12):1835-1841. -
EID Journal: Endemic,
Notifiable Bioterrorism-Related Diseases, United States,
1992-1999
Emerging Infectious Diseases 2003 May;9(5):556-564. -
EID Journal: Use
of Automated Ambulatory-Care Encounter Records for Detection
of Acute Illness Clusters, Including Potential Bioterrorism
Events
Emerging Infectious Diseases 2002 Aug;8(8):753-760. -
MMWR: Recognition
of Illness Associated with the Intentional Release of a
Biologic Agent
MMWR 2001 Oct 19;50(41):893-897.
(168 KB/20 pages)
Infection Control
-
Infection
Control (from Abstract of "Consensus Statement: Tularemia
as a Biological Weapon: Medical and Public Health Management")
Concise, bulleted summary of recommendations from the Working Group on Civilian Biodefense. See also thefull version of the "Infection Control" section of the "Consensus Statement" (JAMA 2001; 285(21):2763-73). - Community-Based Mass Prophylaxis: A Planning Guide for Public Health Preparedness
Planning guide to help state, county, & local officials meet federal requirements to prepare for public health emergencies. Outlines five components of mass prophylaxis response to epidemic outbreaks. Addresses dispensing operations using a comprehensive operational structure for Dispensing/Vaccination Centers (DVCs) based on the National Incident Management System (NIMS). (Developed by Weill Medical College of Cornell University for the Agency of Healthcare Research & Quality [AHRQ].) -
MMWR: Recognition
of Illness Associated with the Intentional Release of a
Biologic Agent
MMWR 2001 Oct 19;50(41):893-897.
(168 KB/20 pages)
Other Resources
-
Video:
"The History of Bioterrorism: Tularemia"
Describes the threat of tularemia as a weapon of bioterrorism
Dec 23, 2003 -
Communicating in the First Hours: Tularemia
The First Hours project provides messages and other resources for federal, state, local, and tribal public health officials to use during a response to an emergency. Developed by CDC in collaboration with the Office of Public Affairs of the U.S. Department of Health and Human Services (HHS). -
Abstract
of "Consensus Statement: Tularemia as a Biological
Weapon: Medical and Public Health Management"
Concise, bulleted summary of recommendations from the Working Group on Civilian Biodefense. See also thefull version of the "Consensus Statement" (JAMA 2001; 285(21):2763-73). -
MMWR: Tularemia—United
States, 1990-2000
MMWR 2002 Mar 8;51(9):182-184.
(368 KB/24 pages)